Life Science

One last idea to think about from The Scientist. It was a sidebar to an article so I’m going to quote it in full here. It raises some questions about what the cost will be–financial and otherwise–with more targeted and presumably, more effective cancer treatments.

From The Scientist “Can we prevent cancer? Absolutely, according to epidemiological data on migrant populations. The Japanese historically have a high incidence of gastric cancer and a low incidence of colon cancer. In the U.S., it is the opposite. In the last half of the twentieth century, upon migration to Hawaii, first generation Japanese saw a dramatic switch in the ...

There are a couple of additional articles in the cancer feature of The Scientist that should be of interest to FI Space.

If you’re interested in science trends that may be contributing to the new twists at NIH, it happens that The Scientist has a feature this week that is all about cancer science. Strap on your molecular biology thinking cap. Aberrant cell signaling. How cells take the wrong fork. DNA expression profiling. Are cancers as distinctive as, say, earlobes? Diagnosing cancer ...